BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 25728134)

  • 1. Emerging influenza viruses and the prospect of a universal influenza virus vaccine.
    Krammer F
    Biotechnol J; 2015 May; 10(5):690-701. PubMed ID: 25728134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2015 Oct; 90(42):561-71. PubMed ID: 26477059
    [No Abstract]   [Full Text] [Related]  

  • 3. Universal influenza vaccines: Shifting to better vaccines.
    Berlanda Scorza F; Tsvetnitsky V; Donnelly JJ
    Vaccine; 2016 Jun; 34(26):2926-2933. PubMed ID: 27038130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal influenza vaccination and technologies.
    Nafziger AN; Pratt DS
    J Clin Pharmacol; 2014 Jul; 54(7):719-31. PubMed ID: 24691877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a universal influenza vaccine: different approaches for one goal.
    Sautto GA; Kirchenbaum GA; Ross TM
    Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal influenza virus vaccines and therapeutic antibodies.
    Nachbagauer R; Krammer F
    Clin Microbiol Infect; 2017 Apr; 23(4):222-228. PubMed ID: 28216325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
    Rudenko L; Yeolekar L; Kiseleva I; Isakova-Sivak I
    Vaccine; 2016 Oct; 34(45):5436-5441. PubMed ID: 27593158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal influenza vaccines: a realistic option?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.
    Wheatley AK; Kent SJ
    Expert Rev Vaccines; 2015; 14(9):1227-39. PubMed ID: 26175180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2018 Mar; 93(12):142-52. PubMed ID: 29569430
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in the development of influenza virus vaccines.
    Krammer F; Palese P
    Nat Rev Drug Discov; 2015 Mar; 14(3):167-82. PubMed ID: 25722244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine.
    Tchilian E; Holzer B
    Viruses; 2017 May; 9(5):. PubMed ID: 28475122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemagglutinin consensus-based prophylactic approaches to overcome influenza virus diversity.
    Sautto GA; Ross TM
    Vet Ital; 2019 Sep; 55(3):195-201. PubMed ID: 31599544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of live attenuated influenza vaccines against pandemic influenza strains.
    Coelingh KL; Luke CJ; Jin H; Talaat KR
    Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
    Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
    Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.